CAPITAL RESEARCH GLOBAL INVESTORS – Teva Pharmaceutical Industries Limited Transaction History
CAPITAL RESEARCH GLOBAL INVESTORS portfolio value:
$945.72M
portfolio value
CAPITAL RESEARCH GLOBAL INVESTORS quarter portfolio value change:
+7.31%
quarter
Teva Pharmaceutical Industries Limited 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +25.79% | 24.02M shares | 245.09M | $8.07 | 117.19M |
| Q2 2022 | share | Decrease | -29.51% | -38.99M shares | -540.41M | $7.52 | 93.16M |
| Q1 2022 | share | Decrease | -0.14% | -185.23K shares | 180.92M | $9.39 | 132.16M |
| Q4 2021 | share | Increase | +11.33% | 13.47M shares | -97.79M | $7.9 | 132.35M |
| Q3 2021 | share | Decrease | -3.08% | -3.77M shares | -56.37M | $9.74 | 118.87M |
| Q2 2021 | share | Decrease | -4.69% | -6.04M shares | -270.81M | $9.9 | 122.65M |
| Q1 2021 | share | Decrease | -1.11% | -1.44M shares | 229.24M | $11.54 | 128.69M |
| Q4 2020 | share | Increase | +0.03% | 32.77K shares | 83.59M | $9.65 | 130.14M |
| Q3 2020 | share | Decrease | -0.02% | -20.47K shares | -432.21M | $9.01 | 130.10M |
| Q2 2020 | share | Increase | +0.03% | 37.14K shares | 436.26M | $12.33 | 130.12M |
| Q1 2020 | share | Decrease | -0.66% | -859.87K shares | -115.11M | $8.98 | 130.09M |
| Q4 2019 | share | Increase | +0.02% | 21.25K shares | 382.52M | $9.8 | 130.95M |
| Q3 2019 | share | Increase | +0.03% | 37.19K shares | -307.34M | $6.88 | 130.92M |
| Q2 2019 | share | Increase | +2.11% | 2.70M shares | -801.90M | $9.23 | 130.89M |
| Q1 2019 | share | Increase | +5.11% | 6.23M shares | 129.50M | $15.68 | 128.19M |
| Q4 2018 | share | Increase | +2.61% | 3.10M shares | -679.46M | $15.42 | 121.95M |
| Q3 2018 | share | Decrease | -2.61% | -3.18M shares | -407.84M | $21.54 | 118.84M |
| Q2 2018 | share | Increase | +0.30% | 363.63K shares | 888.51M | $24.32 | 122.03M |
| Q1 2018 | share | Increase | +23.21% | 22.91M shares | 207.96M | $17.09 | 121.66M |
| Q4 2017 | share | Increase | +40.88% | 28.65M shares | 637.66M | $18.95 | 98.75M |
| Q3 2017 | share | Decrease | -8.16% | -6.22M shares | -1.30B | $17.5 | 70.09M |
| Q2 2017 | share | Increase | +13.81% | 9.26M shares | 383.41M | $32.88 | 76.32M |
| Q1 2017 | share | Increase | +51.06% | 22.66M shares | 542.72M | $31.45 | 67.06M |
| Q4 2016 | share | Increase | +112.67% | 23.52M shares | 648.88M | $35.24 | 44.39M |
| Q3 2016 | share | Increase | +20.91% | 3.60M shares | 93.23M | $44.37 | 20.87M |
| Q2 2016 | share | Increase | +49.57% | 5.72M shares | 249.57M | $48.18 | 17.26M |
| Q1 2016 | share | Increase | +1.37% | 155.8K shares | -129.79M | $51.04 | 11.54M |